Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1924 1
1960 1
2001 1
2002 1
2007 1
2008 2
2009 6
2010 8
2011 9
2012 7
2013 12
2014 10
2015 9
2016 6
2017 5
2018 9
2019 9
2020 7
2021 6
2022 3
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
McDonald CM, Marbán E, Hendrix S, Hogan N, Ruckdeschel Smith R, Eagle M, Finkel RS, Tian C, Janas J, Harmelink MM, Varadhachary AS, Taylor MD, Hor KN, Mayer OH, Henricson EK, Furlong P, Ascheim DD, Rogy S, Williams P, Marbán L; HOPE-2 Study Group. McDonald CM, et al. Among authors: hor kn. Lancet. 2022 Mar 12;399(10329):1049-1058. doi: 10.1016/S0140-6736(22)00012-5. Lancet. 2022. PMID: 35279258 Free article. Clinical Trial.
Koh EJ, Tan JT, Amalina Manan NN, Hor KY, Teh ZY, Chin ML. Koh EJ, et al. Among authors: hor ky. J Ayub Med Coll Abbottabad. 2023 Oct-Dec;35(4):690-692. J Ayub Med Coll Abbottabad. 2023. PMID: 38406963 Free article.
Evaluating the Longevity of the Fontan Pathway.
Kelly JM, Mirhaidari GJM, Chang YC, Shinoka T, Breuer CK, Yates AR, Hor KN. Kelly JM, et al. Among authors: hor kn. Pediatr Cardiol. 2020 Dec;41(8):1539-1547. doi: 10.1007/s00246-020-02452-6. Epub 2020 Nov 8. Pediatr Cardiol. 2020. PMID: 33161457 Free PMC article. Review.
Cardiovascular Measures of All-Cause Mortality in Duchenne Muscular Dystrophy.
Soslow JH, Xu M, Slaughter JC, Crum K, Kaslow JA, George-Durrett K, Raucci FJ Jr, Wilkinson JD, Cripe LH, Hor KN, Spurney CF, Markham LW. Soslow JH, et al. Among authors: hor kn. Circ Heart Fail. 2023 Aug;16(8):e010040. doi: 10.1161/CIRCHEARTFAILURE.122.010040. Epub 2023 Jun 8. Circ Heart Fail. 2023. PMID: 37288563
Cardiac Management of the Patient With Duchenne Muscular Dystrophy.
Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK. Buddhe S, et al. Among authors: hor k. Pediatrics. 2018 Oct;142(Suppl 2):S72-S81. doi: 10.1542/peds.2018-0333I. Pediatrics. 2018. PMID: 30275251 Free PMC article. Review.
Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1.
McDonald CM, Mayer OH, Hor KN, Miller D, Goemans N, Henricson EK, Marden JR, Freimark J, Lane H, Zhang A, Frean M, Trifillis P, Koladicz K, Signorovitch J; PRO-DMD-01 consortium investigators. McDonald CM, et al. Among authors: hor kn. J Neuromuscul Dis. 2023;10(1):67-79. doi: 10.3233/JND-221575. J Neuromuscul Dis. 2023. PMID: 36565131 Free PMC article.
110 results